| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Nov―03 |
Development of a UCOE-Based Lentiviral Vector System for Recombinant COVID-19 Antigen Production in CHO Cells |
Pınar Köse, Kübra Nur Bayindirli, Ali Osman Arslan, Ömer Faruk Anakök |
| 2 |
[GO] |
2025―Jul―18 |
Peptide Epitope-Based Avian IgY Antibodies against SARS-CoV-2 Spike: A Cost Effective Approach for Viral Detection and Neutralization |
G. N. Pramod, Prasan Havlad, Nalina Murthy, Abdul Majid, Jessie Thomas, M. Ghalib Enayathullah, Yogesh Sardana, P. K. Sreeram, S. P. Muthukumar, Tanaji Kudre, Pananghat Gayathri, Kiran Kumar Bokara, Gopinath M. Sundaram, Lakshmikanth Mariyanna, Poornima Priyadarshini |
| 3 |
[GO] |
2025―May―30 |
Design and Evaluation of ATN-161 Analogues as Fusion Inhibitors Targeting Integrins in SARS-CoV-2 |
Marriam Munawar, Naeem-Ul-Haq Khan, Sobia Jabeen, Saman Taj, Rizwan Bashir, Wasim Abbas, Waqar Rauf, Mazhar Iqbal |
| 4 |
[GO] |
2024―Nov―16 |
Utilization of Antiviral Peptides in Treating Coronavirus Infection: An Overview |
Qian Xu, Fangyu Wang, Hua Feng, Qiang Wei, Xuefeng Sun, Guangxu Xing, Gaiping Zhang |
| 5 |
[GO] |
2023―Aug―30 |
Molecular Modelling, Synthesis, and In-Vitro Assay to Identify Potential Antiviral Peptides Targeting the 3-Chymotrypsin-Like Protease of SARS-CoV-2 |
Ryan Faddis, Sydney Du, James Stewart, Mohammad Mehedi Hasan, Noam Lewit, Md Ackas Ali, Cladie B. White, Patience Okoto, Sures Thallapuranam, Mohammad A. Halim |
| 6 |
[GO] |
2023―Jul―17 |
Designing a Novel Spike Linear B-Cell Epitopes (SLBE) Protein with High Performance in Sars-Cov2-ELISA Test |
Majid Esmaelizad, Maedeh Hamidizadeh, Nazanin Esmaelizad, Mohammad Doroudian, Mohammad Ranjbar, Mohsen Lotfi |
| 7 |
[GO] |
2023―May―30 |
Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients |
Motahareh Zeinivand, Masoomeh Sharifi, Gholamhossein Hassanshahi, Seyed Ershad Nedaei |
| 8 |
[GO] |
2022―Aug―22 |
SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective |
Abdo A. Elfiky, Ibrahim M. Ibrahim, Alaa M. Elgohary |
| 9 |
[GO] |
2022―Apr―19 |
Peptide-Based Vaccines and Therapeutics for COVID-19 |
Pritam V. Bagwe, Priyal V. Bagwe, Sai Srinivas Ponugoti, Shreerang V. Joshi |
| 10 |
[GO] |
2022―Mar―16 |
Immunogenic Epitope-Based Vaccine Prediction from Surface Glycoprotein of MERS-CoV by Deploying Immunoinformatics Approach |
Truc Ly Nguyen, Youngho Lee, Heebal Kim |
| 11 |
[GO] |
2022―Jan―24 |
Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19 |
Aparajita Sen, Arti Nigam, Meenakshi Vachher |
| 12 |
[GO] |
2022―Jan―21 |
Exploring Structural Mechanism of COVID-19 Treatment with Glutathione as a Potential Peptide Inhibitor to the Main Protease: Molecular Dynamics Simulation and MM/PBSA Free Energy Calculations Study |
Abderahmane Linani, Khedidja Benarous, Leila Bou-Salah, Mohamed Yousfi, Souraya Goumri-Said |
| 13 |
[GO] |
2022―Jan―03 |
Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus |
Yasaman Behzadipour, Shiva Hemmati |
| 14 |
[GO] |
2022―Jan―03 |
In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein |
Gunderao H. Kathwate |
| 15 |
[GO] |
2021―Dec―13 |
In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern |
Sajjan Rajpoot, Kundan Solanki, Ashutosh Kumar, Kam Y. J. Zhang, Soni Savai Pullamsetti, Rajkumar Savai, Syed M. Faisal, Qiuwei Pan, Mirza S. Baig |
| 16 |
[GO] |
2021―Dec―09 |
In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides |
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi, Reza Mirnejad |
| 17 |
[GO] |
2021―Jul―10 |
Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research |
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee |
| 18 |
[GO] |
2021―Jul―10 |
New Computational Approach for Peptide Vaccine Design Against SARS-COV-2 |
Subhamoy Biswas, Smarajit Manna, Ashesh Nandy, Subhash C. Basak |
| 19 |
[GO] |
2021―Apr―16 |
Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics |
Richa Jain, Ankit Jain, Santosh kumar Verma |
| 20 |
[GO] |
2021―Apr―16 |
Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection |
Abbas Jafari, Sonia Sadeghpour, Hojat Ghasemnejad-Berenji, Sarvin Pashapour, Morteza Ghasemnejad-Berenji |
| 21 |
[GO] |
2021―Apr―08 |
Identification of Potential Peptide Inhibitors of ACE-2 Target of SARS-CoV-2 from Buckwheat & Quinoa |
Ashok Nanjaiah Rangaswamy, Arpitha Ashok, Pradeep Hanumanthappa, Aparanji Sinduvalli Chandrashekaramurthy, Monika Kumbaiah, Pratibha Hiregouda, Vaishali Sharma, Aparna Huligerepura Sosalegowda |
| 22 |
[GO] |
2021―Mar―17 |
In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2 |
M A. Siddiqa, D. S. Rao, G. Suvarna, V. K. Chennamachetty, M. K. Verma, M. V. R. Rao |
| 23 |
[GO] |
2020―Nov―10 |
Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach |
Janish Kumar, Rahila Qureshi, Someswar R. Sagurthi, Insaf Ahmed Qureshi |
| 24 |
[GO] |
2020―Sep―28 |
Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease |
Vijayakumar Balakrishnan, Karthik Lakshminarayanan |
